ArticleWideochirurgia i inne techniki maloinwazyjne = Videosurgery and other miniinvasive techniques2026
Conversion to Roux en Y gastric bypass after sleeve gastrectomy: outcomes from a Middle Eastern cohort.
Article in Wideochirurgia i inne techniki maloinwazyjne = Videosurgery and other miniinvasive techniques, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionConversion from sleeve gastrectomy (SG) to Roux -en -Y gastric bypass (RYGB) is increasingly performed for refractory gastroesophageal reflux disease (GERD), recurrent weight gain, and anatomical complications, although outcome data from Middle Eastern centers remain limited.
aimThis study evaluated the effectiveness of conversion from SG to RYGB in a Middle Eastern cohort.
resultsThe cohort included 32 women at a mean (SD) age of 46 (8) years. Mean (SD) pre‑SG BMI in the study population was 42 (7.2) kg/m2 . According to the main indications for conversion, at 1 year, mean (SD) BMI decreased to 24 (1.9) kg/m2 (GERD), 28 (3.3) kg/m2 (recurrent weight gain), and 27 (2.8) kg/m2 (GERD + recurrent weight gain; P <0.001). Mean (SD) %EWL was 82%, 65%, and 67%, respectively. GERD symptoms improved in 85% of the patients. Type 2 diabetes remission occurred in 58%, hypertension improved in 72%, and complications occurred in 9.1% of the study cohort. Descriptive comparison of laparoscopic and robotic approaches showed similar outcomes, but should be interpreted with caution given the noncontemporaneous treatment periods.
conclusionsConversion to RYGB after SG is effective for weight reduction and GERD symptom improvement, with acceptable morbidity rates.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.